1,200
Participants
Start Date
October 8, 2019
Primary Completion Date
June 27, 2025
Study Completion Date
June 27, 2026
Edoxaban Monotherapy
when the patients will be initially registered in this study, duty physicians will make a decision to give additional antiplatelet therapy in addition to standard edoxaban therapy.
Asan Medical Center, Seoul
Lead Sponsor
Samsung Medical Center
OTHER
Myongji Hospital
OTHER
Ewha Womans University
OTHER
Chonbuk National University
OTHER
Pusan National University Hospital
OTHER
Korea University Ansan Hospital
OTHER
Keimyung University Dongsan Medical Center
OTHER
Chonnam National University Hospital
OTHER
Korea University Guro Hospital
OTHER
Chungnam National University Hospital
OTHER
Chung-Ang University Hosptial, Chung-Ang University College of Medicine
OTHER
Kyungpook National University Hospital
OTHER
Dongtan Sacred Heart Hospital
OTHER
Eulji University Hospital
OTHER
Asan Medical Center
OTHER